The CMO as a Translational Scientist

Summary:

This podcast features a panel discussion from the 2024 Chief Medical Officer Summit 360° on how biotech CMOs can set their assets up for success before getting into the clinic, the key skills needed to bridge the scientific and clinical functions of the company and how to collaborate effectively with CSOs.

To learn more about the CMO Summit 360°, please visit CMO360.org.

Moderators
Joseph Elassal, MD, MBA
CMO
Ankyra Therapeutics
Panelists
Steven Katz, MD
CMO and SVP, Translational Research
Shinobi Therapeutics
Andrea Wang-Gillam, MD, PhD
Co-CEO
Jacobio Pharmaceuticals
This content was created by The Conference Forum staff. The Fierce editorial team did not contribute to this work.